Publications

HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.

GILHAM, C; Sargent, A; Kitchener, HC; PETO, J;

2019

Health Technol Assess, (2019).23 28 10.3310/hta23280.

User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study.

Haldane, V; Koh, JJ K; Srivastava, A; Teo, KW Q; Tan, YG; Cheng, RX; Yap, YC; Ong, P-S; Van Dam, RM; Foo, JM; Müller-Riemenschneider, F; Koh, GC-H; Foong, PS; PEREL, P; LEGIDO-QUIGLEY, H;

2019

JMIR mHealth and uHealth, (2019).7 5 10.2196/10465.

Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.

Gupta, P; PRIETO-MERINO, D; Ajay, VS; Singh, K; Roy, A; Krishnan, A; Narayan, KM V; Ali, MK; Tandon, N; PRABHAKARAN, D; PEREL, P;

2019

Wellcome Open Research, (2019).4 71 10.12688/wellcomeopenres.15137.1.

Can a nurse-led community-based model of hypertension care improve hypertension control in Ghana? Results from the ComHIP cohort study.

ADLER, AJ; Laar, A; PRIETO-MERINO, D; Der, RM M; Mangortey, D; Dirks, R; LAMPTEY, P; PEREL, P;

2019

BMJ open, (2019).9 4 10.1136/bmjopen-2018-026799.

Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study.

Haldane, V; Tan, YG; Teo, KW Q; Koh, JJ K; Srivastava, A; Cheng, RX; Yap, YC; Ong, P-S; Van Dam, RM; Foo, JM; Müller-Riemenschneider, F; Koh, GC-H; PEREL, P; LEGIDO-QUIGLEY, H;

2019

JMIR mHealth and uHealth, (2019).7 3 10.2196/11108.

The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries.

Kehlenbrink, S; SMITH, J; ANSBRO, É; FUHR, DC; Cheung, A; RATNAYAKE, R; Boulle, P; Jobanputra, K; PEREL, P; ROBERTS, B;

2019

LANCET DIABETES & ENDOCRINOLOGY, (2019).7 8 10.1016/S2213-8587(19)30082-8.

Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review.

Carrillo-Larco, RM; Altez-Fernandez, C; Pacheco-Barrios, N; Bambs, C; Irazola, V; MIRANDA, JJ; Danaei, G; PEREL, P;

2019

GLOBAL HEART, (2019).14 1 10.1016/j.gheart.2019.03.001.

Who makes the decision to receive Oxaliplatin among stage III colorectal cancer (CRC) patients?.

HASSAN, S; Miles, A; MORRIS, M;

2019

PSYCHO-ONCOLOGY, (2019).28,

High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.

RAKE, C; GILHAM, C; Bukasa, L; Ostler, R; Newton, M; Peto Wild, J; Aigret, B; Hill, M; Gillie, O; Nazareth, I; Sasieni, P; Martineau, A; PETO, J;

2018

Health technology assessment (Winchester, England), (2018).24 10 10.3310/hta24100.

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.

BENITEZ MAJANO, S; Di Girolamo, C; RACHET, B; MARINGE, C; Guren, MG; Glimelius, B; Iversen, LH; Schnell, EA; Lundqvist, K; Christensen, J; MORRIS, M; COLEMAN, MP; WALTERS, S;

2018

The Lancet Oncology, (2018).20 1 10.1016/S1470-2045(18)30646-6.